

Transactions
Showing results for
Healthcare
and
France
1 to 16 of 35
Healthcare
Advised
- Sanofi
on the sale of
- OTC products BoxaGrippal® and Heumann Tee to Angelini Pharma
Value: €47m
Healthcare
Advised
- Almaviva Santé & Antin IP
on the acquisition of
- Turin & Monceau Private Hospitals
Healthcare
Advised
- Taisho Pharmaceuticals
on the acquisition of
- UPSA from Bristol-Myers Squibb Company
Value: ¥1.6bn
Healthcare
Advised
- Jouvence Nutrition
on its sale to
- Group Inicea
Healthcare
Advised
- Eurazeo Patrimoine
on the acquisition of
- C2S
Healthcare
Advised
- Duke Street and Baywater Healthcare
on the sale to
- Bastide le Confort Medical
Healthcare
Advised
- Capzanine, BNP Parisbas Développement and the founding shareholders
on the sale of
- Direct Medica to Webhelp Group
Healthcare
Advised
- Hôpital Privé de l'Est Lyonnais
on its sale to
- Ramsay Générale de Santé
Healthcare
Advised
- Le Normandy
on its sale to
- Groupe Clinique Développement
Healthcare
Advised
- Domidep
on the refinancing of existing debt facilities
Healthcare
Advised
- Paramount Bed Holdings
on the sale of
- Corona Medical
Healthcare
Advised
- Groupe Oméga
on its sale to
- Siparex and GSO Capital
Healthcare
Advised
- Avenir Santé
on its sale to
- Groupe C2S
Healthcare
Advised
- Acteon
on its sale to
- Bridgepoint Development Capital
Healthcare
Advised
- IP Santé
on the acquisition of
- AMS Médical
For important information regarding transactions, please see our disclaimer.